New York State Common Retirement Fund
BIOA

New York State Common Retirement Fund’s BioAge Labs BIOA Stock Holding History

New York State Common Retirement Fund’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$304K Buy
12,400
+7,300
+143% +$132K ﹤0.01% 2205
2026
Q1 		$89.2K Hold
5,100
– – ﹤0.01% 2577
2025
Q4 		$67.5K Hold
5,100
– – ﹤0.01% 2811
2025
Q3 		$30K Hold
5,100
– – ﹤0.01% 3056
2025
Q2 		$21.1K Hold
5,100
– – ﹤0.01% 3108
2025
Q1 		$19.2K Buy
+5,100
New +$23.6K ﹤0.01% 2986

Other funds holding BIOA

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
ACM
Alessandra Capital Management Torrance, California $141M AUM
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Common Retirement Fund's BIOA Position: Q2 2026 in Review

New York State Common Retirement Fund increased its BioAge Labs (BIOA) stake by 143% in Q2 2026, buying an estimated $132K and bringing the position to 12,400 shares worth $304K. The position accounts for ﹤0.01% of the portfolio, ranked #2205.

New York State Common Retirement Fund first reported a position in BIOA in Q1 2025 and has held it in 6 quarters since. 23 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • New York State Common Retirement Fund held 12,400 shares of BioAge Labs worth $304K as of Q2 2026.
  • New York State Common Retirement Fund bought 7,300 BioAge Labs shares in Q2 2026, an estimated $132K.
  • BioAge Labs made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2205 holding.
  • New York State Common Retirement Fund first reported a position in BioAge Labs in Q1 2025 and has held it in 6 quarters since.
  • 23 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.